Biol 20: Chapter 14

Continuation of Chapter 30: Control of Microorganisms and Antibiotics

  • Introduction to Antibiotics

    • Antibiotics are derived from two main types of chemicals:

      • Natural Chemicals: Produced and extracted from live organisms.

      • Artificial Chemicals: Man-made or synthetic chemicals.

  • Historical Background of Antibiotics

    • Edward Fleming's discovery of penicillin in 1928 is pivotal:

      • It was considered a wonder drug during the 1940s.

      • Helped save many lives, particularly during World War II, allowing wounded soldiers to recover from infections.

    • Recent challenges with antibiotics include the rise of superbugs due to overuse.

  • Definitions and Key Terminology

    • Antibiotic: Chemicals/substances from living organisms that can kill microbes.

    • Antimicrobial Drugs: Include both natural and artificial compounds targeting micro-organisms.

    • Selective Toxicity: The ability of drugs to selectively target pathogens without damaging host cells. Some antimicrobials lack this feature, leading to side effects.

  • Important Figures in Antibiotic Discovery

    • Alexander Fleming: Discovered penicillin using staphylococcus aureus in 1928 after a contamination incident where he noted that mold disrupted bacterial growth.

    • Howard Florey and Ernst Boris Chain: Conducted the first human trials of penicillin, leading to public release.

    • Selman Waksman: Studied soil microorganisms, discovering actinobacteria which produce numerous antibiotics.

    • Paul Ehrlich: Developed "Magic Bullet," an arsenic compound (Compound 606) used to treat syphilis and gonorrhea, marking the beginning of chemotherapy.

  • Antibiotic Types and Usage

    • Bactericidal: Antibiotics that kill bacteria.

    • Bacteriostatic: Antibiotics that inhibit bacterial growth; may not be sufficient for severe infections.

    • Broad Spectrum Antibiotics: Effective against a wide range of bacteria (both Gram-positive and Gram-negative). Used when pathogens are unidentified or for mixed infections.

    • Narrow Spectrum Antibiotics: Target specific types of bacteria. Effective when the pathogen is known, reducing the risk of superinfections.

  • Risks of Antibiotic Usage

    • Overuse can lead to superinfections where resistant bacteria flourish due to the loss of normal microbiota.

    • It is important to complete antibiotic courses to eliminate all pathogenic bacteria and reduce the development of resistance.

  • Administration Routes of Antibiotics

    • Oral: Convenient but slower absorption; not ideal for critically ill patients.

    • Intravenous (IV): Rapid and effective for severe illnesses.

    • Intramuscular (IM): Also effective but slightly slower than IV.

    • Topical: Used for superficial skin infections.

  • Clinical Considerations

    • Physicians must choose the appropriate antibiotic type based on infection type, patient health, and infection severity.

    • Regular assessments and adjustments to treatment plans are key to effective resolution of infections.

    • Awareness of potential side effects and the importance of maintaining gut flora during antibiotic treatment is crucial.

video 2

  • Chapter 14: Antimicrobial Drugs

  • Introduction to Antibiotics

    • Discussion of historical figures: Paul Elbrick, Lori and Shane, Salman Watsman.

    • Compound 606 introduced for syphilis; noted as the first antimicrobial agent.

    • Definition of terms related to antibiotic action and spectrum:

      • Bactericidal: kills bacteria.

      • Bacteriostatic: inhibits the growth of bacteria.

      • Broad Spectrum: effective against a wide range of bacteria (both Gram-positive and Gram-negative).

      • Narrow Spectrum: effective against specific types of bacteria.

  • Effects of Long-Term Use of Broad Spectrum Antibiotics:

    • Can lead to superinfections and resistance development.

    • Importance of understanding patient medication history to avoid adverse interactions (e.g., antacids affecting antibiotic absorption).

  • Route of Administration:

    • Oral: most convenient but may undergo degradation in the GI tract.

    • Intravenous (IV): delivers the drug directly into the bloodstream, faster effects.

    • Intramuscular (IM): involves invasive methods (parental route).

  • Drug Interactions:

    • Synergism: combination of drugs produces a greater effect (e.g., combination therapy for HIV).

    • Antagonism: drugs may counteract each other; importance of disclosing all medications to the healthcare provider.

      • Example: taking antacids can interfere with antibiotic efficacy by altering gastric pH.

  • Example of pH Impact on Drug Absorption:

    • Regular antacid use can elevate stomach pH and negatively impact digestion and absorption of medications.

  • The Role of the Liver:

    • The liver is a crucial organ for processing all substances entering the bloodstream, acting as a filtering system before circulation.

  • Important Bacterial Genera:

    • Staphylococcus aureus (Fleming’s observation).

    • Streptococcus pyogenes (narrow-spectrum antibiotic treatment).

  • Antimicrobial Drug Classifications:

    • Focus on various antibiotics targeting different cellular mechanisms:

      • Cell Wall Inhibitors:

        • Beta-lactam antibiotics (e.g., penicillins, cephalosporins).

        • Example: Methicillin for staph; resistance development to penicillin.

      • Protein Synthesis Inhibitors:

        • Target ribosomal subunits; aminoglycosides (30S) and macrolides (50S).

        • Chloramphenicol has associated risks (aplastic anemia in newborns).

      • Metabolic Pathway Inhibitors:

        • Sulfonamides, trimethoprim - impact on folic acid synthesis.

      • Nucleic Acid Synthesis Inhibitors:

        • Fluoroquinolones (e.g., ciprofloxacin) targeting DNA gyrase.

        • Rifampin used to treat tuberculosis (TB) along with isoniazid (mycolic acid synthesis inhibitor).

  • Viral and Fungal Infections:

    • Antifungal strategies target chitin and ergosterol, unique to fungal cells.

    • Antiviral drugs exist but are limited due to viral mutation rates; key drugs include acyclovir for herpes.

  • Antibiotic Resistance:

    • Resistance mechanisms: blocking entry, inactivating enzymes, altering targets, and efflux pumps.

    • Understanding escape pathogens (e.g., Enterococcus faecium, Staphylococcus aureus) as significant clinical challenges.

  • Recap of Key Points and Questions:

  • Importance of antibiotic stewardship to prevent resistance development.

  • Prepare for next topics (Chapters 8 and 10).